Molecular profiling to determine the tissue of origin of a patient’s CUP is not routinely undertaken in the UK – yet it is often a helpful aid to achieving an accurate diagnosis to allow focused treatment with confidence. The NHS need to be convinced of the cost/benefits of molecular profiling for CUP patients. A Canadian study has investigated the cost-effectiveness of
Read more
We are an apolitical charity but on the realistic grounds that the Conservatives are most likely to regain power at the General Election it is interesting to note their manifesto commitment to: ‘continuing to support research into the diagnosis and treatment of rare cancers and other diseases, including Genomics England’s work in decoding 100,000 genomes’. What does it mean beyond
Read more